Skip to main content
. 2019 Feb 28;36(2):78–87. doi: 10.4274/balkanmedj.galenos.2018.2018.1195

Figure 2.

Figure 2

AML risk categories and associated molecular abnormalities. (FLT3-ITD low : FLT3-ITD/wild type allelic ratio <0.5; FLT3-ITD high : FLT3-ITD/wild type allelic ratio >0.5)

AML: acute myeloid leukemia